KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

GoodRx Holdings (GDRX) FCF Margin (2019 - 2025)

Historic FCF Margin for GoodRx Holdings (GDRX) over the last 7 years, with Q3 2025 value amounting to 30.49%.

  • GoodRx Holdings' FCF Margin fell 60800.0% to 30.49% in Q3 2025 from the same period last year, while for Sep 2025 it was 13.41%, marking a year-over-year increase of 20300.0%. This contributed to the annual value of 14.49% for FY2024, which is 33500.0% up from last year.
  • GoodRx Holdings' FCF Margin amounted to 30.49% in Q3 2025, which was down 60800.0% from 15.59% recorded in Q2 2025.
  • GoodRx Holdings' FCF Margin's 5-year high stood at 36.57% during Q3 2024, with a 5-year trough of 6.07% in Q1 2025.
  • Its 5-year average for FCF Margin is 14.44%, with a median of 14.23% in 2024.
  • Examining YoY changes over the last 5 years, GoodRx Holdings' FCF Margin showed a top increase of 192100bps in 2025 and a maximum decrease of -173800bps in 2025.
  • Over the past 5 years, GoodRx Holdings' FCF Margin (Quarter) stood at 19.39% in 2021, then crashed by -53bps to 9.09% in 2022, then tumbled by -81bps to 1.73% in 2023, then soared by 722bps to 14.23% in 2024, then skyrocketed by 114bps to 30.49% in 2025.
  • Its FCF Margin stands at 30.49% for Q3 2025, versus 15.59% for Q2 2025 and 6.07% for Q1 2025.